This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Saskatchewan directory, so their courses may be missing. Find their university profile.
Latest papers
Corrigendum to 'The yes-associated protein-1 (YAP1) inhibitor celastrol suppresses the ability of transforming growth factor β to activate human gingival fibroblasts' [Archives of Oral Biology 160 (2024) 105910].
Archives of oral biology · 2026 · senior author
Interview with Neha Dinesh, American Society for Matrix Biology Founders Award recipient.
Matrix biology : journal of the International Society for Matrix Biology · 2026 · first author
Crosstalk of the Hippo/YAP pathway in the progression of oral potentially malignant disorders to oral squamous cell carcinoma: a systematic review.
Frontiers in oral health · 2026
Latest funding
- $1,044,226
The contribution of CCN proteins to scleroderma fibrosis: cellular and molecular mechanisms
CIHR · 2022 · Nominated PI
- $100,000
The contribution of CCN proteins to scleroderma fibrosis: cellular and molecular mechanisms
CIHR · 2021 · Nominated PI
45 publications.
Corrigendum to 'The yes-associated protein-1 (YAP1) inhibitor celastrol suppresses the ability of transforming growth factor β to activate human gingival fibroblasts' [Archives of Oral Biology 160 (2024) 105910].
Naik A, Chitturi P, Nguyen J, Leask A
Interview with Neha Dinesh, American Society for Matrix Biology Founders Award recipient.
Leask A, Fadl A, Dinesh NEH
Crosstalk of the Hippo/YAP pathway in the progression of oral potentially malignant disorders to oral squamous cell carcinoma: a systematic review.
Kazemi KS, de Castro Costa M, de Carli ML, Leask A, Franca CM, Sperandio FF
SYISL promotes pulmonary epithelial-mesenchymal transition and fibrosis through DSP-Hippo/YAP pathway.
Xia C, Hou S, Wang X, Zhao W, Wang Z, Chang A, Cheng L, Liu H, Wang J, Li B, Pan X, Huang S, Cao Y, Koji S, Li Z, Wang Q, Leask A, Wang L, Yu G
A Pan-Cancer Transcriptomic Signature for Conserved Molecular Programs Underlying Premalignant-Malignant Progression Across Common Carcinomas.
Kazemi KS, Miyazawa M, Hanemann JAC, Ionta M, Oliveira PF, Leask A, Franca CM, Sperandio FF
CCN1: a SASPy protein that plays multifaceted roles in fibrogenesis.
Leask A
The Areca Nut and Oral Submucosal Fibrosis: A Narrative Review.
Kazemi K, Fadl A, Sperandio FF, Leask A
George R. Martin: Pioneering matrix biologist.
Leask A, Stratton RJ
Endothelial cell (EC)-specific Ctgf/Ccn2 expression increases EC reprogramming and atherosclerosis.
Li F, Kumar S, Pokutta-Paskaleva A, Kang DW, Kim C, Raykin J, Omojola V, Hoffmann C, Zhao F, Teichmann M, Park C, In Baek K, Sanchez Marrero G, Ma J, Yanagisawa H, Leask A, Timmins L, Cui X, Sutliff R, Gleason RL, Jo H, Brewster LP
CCN2: A potential contributor to gingival overgrowth.
Fadl A, Leask A
The contribution of CCN proteins to scleroderma fibrosis: cellular and molecular mechanisms
Principal investigators: Leask, Andrew C
Keywords: Ccn Proteins; Connective Tissue; Fibrosis; Matricellular Proteins; Microenvironment; Scleroderma
The contribution of CCN proteins to scleroderma fibrosis: cellular and molecular mechanisms
Principal investigators: Leask, Andrew C
Keywords: Ccn Proteins; Connective Tissue; Fibrosis; Matricellular Proteins; Microenvironment; Scleroderma
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Biomedical and Molecular Sciences
- Psychiatry
- Other
Co-authors at University of Saskatchewan, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.